Skip to main content
HRES 343 112th Congress House Health First Amendment rights Health care costs and insurance Health information and medical records Health personnel Marketing and advertising Prescription drugs Right of privacy State and local government operations Supreme Court

Expressing disapproval of the decision by the Supreme Court in Sorrell v. IMS Health Inc.

Introduced: July 8, 2011 Introduced by: Markey, Edward J. Democratic · Massachusetts See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 25, 2011
Referred to the Subcommittee on the Constitution.
Jul 15, 2011
Referred to the Subcommittee on Health.
Jul 8, 2011
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 8, 2011
Introduced in House
 Plain-English summary Congressional Research Service

Disapproves of the majority opinion in Sorrell v. IMS Health Inc., because it puts prescribers at risk of having their prescriber-identifying information sold without their knowledge or consent.

Expresses the belief of the House of Representatives that: (1) the Supreme Court incorrectly applied a heightened First Amendment standard of review to an instance of commercial regulation; (2) the negative impact on a pharmaceutical manufacturer's ability to market its products is outweighed by the interests of patient safety, doctor privacy, and health care costs; and (3) the states have the right to regulate the pharmaceutical industry based on what is best for the health and safety of their residents.

What's happening now August 25, 2011

Referred to the Subcommittee on the Constitution.

 Committees of jurisdiction 4